ruxolitinib
Showing 26 - 50 of 181
Discoid Lupus Erythematosus Trial in Rochester (Ruxolitinib)
Enrolling by invitation
- Discoid Lupus Erythematosus
- Ruxolitinib
-
Rochester, New YorkUR Medicine Dermatology College Town
May 20, 2022
Myelofibrosis Due to and Following Polycythemia Vera Trial in United States (Ruxolitinib, Abemaciclib)
Recruiting
- Myelofibrosis Due to and Following Polycythemia Vera
- Ruxolitinib
- Abemaciclib
-
Basking Ridge, New Jersey
- +6 more
Jan 26, 2023
Chronic Myelomonocytic Leukemia, Leukemia Trial in United States (Ruxolitinib)
Active, not recruiting
- Chronic Myelomonocytic Leukemia
- Leukemia
- Ruxolitinib
-
Tampa, Florida
- +4 more
Nov 11, 2022
Acute Myeloid Leukemia, Myeloid and Monocytic Leukemia, MDS Trial in Minneapolis, Saint Louis, Rochester (Decitabine,
Completed
- Acute Myeloid Leukemia
- +2 more
- Decitabine
- +2 more
-
Minneapolis, Minnesota
- +2 more
Nov 2, 2022
Acute Lymphoblastic Leukemia, in Relapse, Lymphoblastic Lymphoma (Precursor B-Lymphoblastic Lymphoma/Leukaemia) Recurrent,
Not yet recruiting
- Acute Lymphoblastic Leukemia, in Relapse
- +4 more
- Ruxolitinib
- +5 more
-
Utrecht, NetherlandsPrincess Máxima Center for Pediatric Oncology
Feb 16, 2023
Acute Lymphoblastic Leukemia Trial in New York (Ruxolitinib, Dasatinib, Dexamethasone)
Active, not recruiting
- Acute Lymphoblastic Leukemia
- Ruxolitinib
- +2 more
-
New York, New YorkMemorial Sloan Kettering Cancer Center
Jul 25, 2022
Necrobiosis Lipoidica Trial in Scottsdale (Ruxolitinib)
Completed
- Necrobiosis Lipoidica
- Ruxolitinib
-
Scottsdale, ArizonaMayo Clinic in Arizona
Mar 17, 2022
Hemophagocytic Lymphohistiocytosis Trial in United States (Ruxolitinib, Dexamethasone, Etoposide)
Recruiting
- Hemophagocytic Lymphohistiocytosis
- Ruxolitinib
- +2 more
-
Phoenix, Arizona
- +9 more
Jan 9, 2023
Acute Myeloid Leukemia, Acute Myeloid Leukemia in Remission, Allogeneic Stem Cell Transplantation Trial in United States
Recruiting
- Acute Myeloid Leukemia
- +2 more
- Ruxolitinib
-
Boston, Massachusetts
- +5 more
Oct 21, 2022
Advanced Cutaneous Squamous Cell Carcinoma Trial in Atlanta, Chicago, New York (Ruxolitinib)
Recruiting
- Advanced Cutaneous Squamous Cell Carcinoma
- Ruxolitinib
-
Atlanta, Georgia
- +2 more
Jun 28, 2022
Myelofibrosis Trial in United States (Ruxolitinib, Thalidomide)
Active, not recruiting
- Myelofibrosis
- Ruxolitinib
- Thalidomide
-
Middletown, New Jersey
- +6 more
Aug 23, 2022
Polycythemia Vera Trial (Ruxolitinib)
Available
- Polycythemia Vera
- Ruxolitinib
- (no location specified)
Mar 7, 2022
Autoimmune Polyendocrinopathy Candidiasis Ectodermal Dystrophy (Apeced), Alopecia Areata Trial run by the National Institute of
Recruiting
- Autoimmune Polyendocrinopathy Candidiasis Ectodermal Dystrophy (Apeced)
- Alopecia Areata
- Ruxolitinib
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Aug 17, 2022
Macrophage Activation Syndrome Trial (Ruxolitinib, methylprednisolone)
Not yet recruiting
- Macrophage Activation Syndrome
- Ruxolitinib
- methylprednisolone
- (no location specified)
Mar 16, 2022
Lymphoma Trial in United States (Ruxolitinib)
Recruiting
- Lymphoma
- Ruxolitinib
-
Miami, Florida
- +9 more
Oct 5, 2022
Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Recurrent Acute Myeloid Leukemia, Refractory Acute
Active, not recruiting
- Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome
- +2 more
- Ruxolitinib
- Venetoclax
-
Columbus, Ohio
- +2 more
Aug 10, 2022
Acute-graft-versus-host Disease, Chronic Graft-versus-host-disease, Solid Organ Transplant Trial in Cincinnati (Ruxolitinib)
Recruiting
- Acute-graft-versus-host Disease
- +2 more
- Ruxolitinib
-
Cincinnati, OhioCincinnati Children's Hospital Medical Center
Mar 31, 2022
Myelofibrosis, Polycythemia Vera Trial in United States (TGR-1202, ruxolitinib)
Active, not recruiting
- Myelofibrosis
- Polycythemia Vera
- TGR-1202
- ruxolitinib
-
Phoenix, Arizona
- +4 more
Jun 20, 2022
T Cell Leukemia, Adult, Leukemia, Adult T-Cell, T Cell Leukemia, HTLV I Associated Trial run by the NCI (Ruxolitinib,
Completed
- T Cell Leukemia, Adult
- +2 more
- Ruxolitinib
- ruxolitinib
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Jan 26, 2022
BCR-JAK2 Fusion Protein Expression, Blasts 20 Percent or Less of Peripheral Blood White Cells, Blasts More Than 5 Percent of
Recruiting
- BCR-JAK2 Fusion Protein Expression
- +11 more
- Ruxolitinib
-
Palo Alto, California
- +3 more
Oct 5, 2022
Kohlmeier Degos Disease With Neurologic Involvement Trial run by the National Heart, Lung, and Blood Institute (NHLBI)
Recruiting
- Kohlmeier Degos Disease With Neurologic Involvement
- Ruxolitinib
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Aug 23, 2023
Myelofibroses Trial in Saint Louis (Pevonedistat, Ruxolitinib, Peripheral blood draw)
Terminated
- Myelofibroses
- Pevonedistat
- +3 more
-
Saint Louis, MissouriWashington University School of Medicine
Dec 16, 2021